Mitra Tewes

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

Dirk Strumberg, Heike Richly, Ralf A. Hilger et al. · Journal of Clinical Oncology · 2004 · 870 citations · Full text

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

Bahriye Aktas, Mitra Tewes, Tanja Fehm et al. · Breast Cancer Research · 2009 · 729 citations · Full text

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

U. Vanhoefer, Mitra Tewes, Federico Rojo et al. · Journal of Clinical Oncology · 2003 · 259 citations

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

Mitra Tewes, Bahriye Aktas, Anja Welt et al. · Breast Cancer Research and Treatment · 2008 · 204 citations · Full text

Prognostic Biomarkers, Metastatic Breast Cancer, Oncology +12

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

Bahriye Aktas, Volkmar Müller, Mitra Tewes et al. · Gynecologic Oncology · 2011 · 125 citations

Breast Oncology, Medicine, Pathology +9